长春安沃高新生物制药有限公司

长春安沃高新生物制药有限公司成立于2019年3月，注册资本为2亿美元，坐落在长春市高新北区北湖开发区，是由长春高新技术产业（集团）股份有限公司与冰岛Alvotech. Hf（安沃泰克）合资建立的集靶向抗体药物研发、生产、销售于一体的高新技术企业。
Changchun Alvotech &CCHN Bio-Pharmaceutical Co., Ltd. was founded in March 2019 by Alvotech Hf and Changchun High-tech Industry (Group) Co., Ltd., which had a registered capital of US $200 million. The company is located in Changchun Beihu Science and Technology Development Zone, China. Changchun Alvotech &CCHN Bio-Pharmaceutical Co., Ltd. is engaged in the research and development, production, sales in one of the high-tech JV.